638 EUR
10.6
1.69%
Last update Dec 17, 2:43 PM CET
Pre-market
Day range
632.59998
638
Previous close
627.40002
Open
632.59998
Access this stock data via API
Subscribe
Regeneron Pharmaceuticals Inc.
638.00
10.60
1.69%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 3.2B 3.1B 2.6B 3.2B
Cost of revenue 444.7M 452.0M 395.8M 482.0M
Gross profit 2.8B 2.7B 2.2B 2.7B
Operating expense
Research & development 1.3B 1.2B 1.1B 1.2B
Selling general and admin 560.8M 540.6M 539.6M 675.3M
Other operating expenses -8.5M 13.2M
Operating income 946.2M 920.3M 504.4M 844.1M
Non operating interest income
Income 149.3M 149.0M 147.9M 156.1M
Expense 16.5M 3.1M 7.4M 9.0M
Other income expense 424.2M 228.5M 126.6M -174.5M
Pretax income 1.5B 1.3B 771.5M 816.8M
Tax provision 258.6M 108.4M 82.1M 34.4M
Net income 1.2B 1.2B 689.4M 782.3M
Basic EPS 13.2 7.6 8.5
Diluted EPS 12.8 7.3 8.1
Basic average shares 89.6M 91.0M 91.7M
Diluted average shares 92.6M 94.8M 97.0M
EBITDA 1.2B 1.2B 768.0M 1.1B
Net income from continuing op. 1.2B 1.2B 689.4M 782.3M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Pre-market

Exchange is currently open for pre-market.
Main market opens in 20 minutes

08:39
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:00
Main market
09:00 - 17:30
All times are displayed in the Europe/Rome timezone (CET, UTC+01:00).